<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 16.1: Differential Diagnosis: Distinguishing Thyroid Dysfunction from Perimenopause</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/GOLD theme for Advanced Cases */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4c1d95;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4c1d95;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6d28d9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e1b4b;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #6d28d9;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffbeb;
            border: 2px solid #d97706;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #d97706;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef3c7;
            border-radius: 8px;
            border-left: 4px solid #d97706;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #4c1d95;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 13px;
            margin-bottom: 15px;
            display: block;
        }

        /* References */
        .references-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            font-size: 14px;
            color: #4b5563;
            margin-top: 50px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1f2937;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 40px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 16: Advanced Case Studies</p>
            <h1 class="lesson-title">Lesson 1: Differential Diagnosis: Distinguishing Thyroid Dysfunction from Perimenopause</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Clinical Twins: Overlapping Symptoms</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The 'T' Pillar: Tracking Symptom Velocity</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Lab Interpretation Framework</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Estrogen-Thyroid Connection</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Case Study: The Metabolic Stall</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Dual-Track Support Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the physiological overlap between hypothyroidism and perimenopause to prevent clinical misidentification.</li>
                <li>Utilize the <span class="highlight">Track Symptoms (T)</span> pillar to differentiate between cyclical hormonal shifts and constant endocrine dysfunction.</li>
                <li>Interpret thyroid lab panels (TSH, fT3, fT4, rT3) through an "optimal" lens rather than just "normal" ranges.</li>
                <li>Understand the biochemical mechanism by which estrogen dominance impacts thyroid hormone availability.</li>
                <li>Design a dual-track support plan integrating Hormone Harmony (H) and Reset Metabolism (R) for complex cases.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Clinical Twins: Overlapping Symptoms</h2>
        <p>In the world of midlife health, hypothyroidism and perimenopause are often referred to as "clinical twins." Because the <span class="highlight">Hypothalamic-Pituitary-Thyroid (HPT)</span> axis and the <span class="highlight">Hypothalamic-Pituitary-Gonadal (HPG)</span> axis share a common control center‚Äîthe hypothalamus‚Äîdysfunction in one frequently triggers or mimics dysfunction in the other.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">26%</div>
                    <div class="stat-label">Women over 45 with Subclinical Hypo</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">8:1</div>
                    <div class="stat-label">Female to Male Thyroid Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">60%</div>
                    <div class="stat-label">Thyroid Issues Undiagnosed</div>
                </div>
            </div>
        </div>

        <p>A 2021 study published in the <em>Journal of Women‚Äôs Health</em> found that nearly <span class="highlight">30% of women</span> seeking treatment for menopausal symptoms were actually presenting with undiagnosed thyroid disorders. The tragedy of this overlap is that a woman may be prescribed HRT when she needs thyroid support, or synthroid when she needs progesterone‚Äîor, most commonly, she needs both but only receives one.</p>

        <h2 id="section2">2. The 'T' Pillar: Tracking Symptom Velocity</h2>
        <p>As an AccrediPro Menopause Support Coach, your primary tool in differential diagnosis is the <span class="highlight">Track Symptoms (T)</span> pillar of the T.H.R.I.V.E. Methodology‚Ñ¢. We are not looking just at *what* the symptom is, but *when* and *how* it manifests.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Symptom</th>
                        <th>Perimenopause Pattern (Cyclical)</th>
                        <th>Thyroid Pattern (Constant)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fatigue</strong></td>
                        <td>Fluctuates; often worst in the luteal phase or during "estrogen crashes."</td>
                        <td>Pervasive; "heavy" feeling regardless of the time of month or sleep quality.</td>
                    </tr>
                    <tr>
                        <td><strong>Weight Gain</strong></td>
                        <td>Central adiposity (belly fat); feels like a sudden shift in "shape."</td>
                        <td>Systemic gain; often accompanied by puffiness (myxedema) in face/ankles.</td>
                    </tr>
                    <tr>
                        <td><strong>Mood</strong></td>
                        <td>Irritability, rage, and acute anxiety ("wired but tired").</td>
                        <td>Apathy, "brain fog," and low-grade depression or flatness.</td>
                    </tr>
                    <tr>
                        <td><strong>Body Temp</strong></td>
                        <td>Hot flashes followed by chills; erratic temperature regulation.</td>
                        <td>Feeling "cold to the bone"; low basal body temperature (<97.8¬∞F).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>If a client tracks her symptoms for 60 days and the fatigue is <span class="highlight">constant and linear</span>, thyroid involvement is highly probable. If the fatigue lifts for 7-10 days mid-cycle, we are likely looking at the "Estrogen Rollercoaster" discussed in Module 2.</p>

        <h2 id="section3">3. The Lab Interpretation Framework</h2>
        <p>Standard medicine often relies solely on TSH (Thyroid Stimulating Hormone). However, in the perimenopausal transition, TSH can be misleadingly "normal" while the client is suffering from <span class="highlight">tissue-level hypothyroidism</span>. To truly distinguish the two, we must look at the full panel through an optimal lens.</p>

        <h3>Optimal vs. Standard Lab Ranges</h3>
        <ul>
            <li><strong>TSH:</strong> Standard (0.5‚Äì4.5 mIU/L) vs. <strong>Optimal (1.0‚Äì2.0 mIU/L)</strong>. A TSH above 2.5 in a perimenopausal woman is a "Yellow Flag" for metabolic stall.</li>
            <li><strong>Free T4:</strong> The storage hormone. We want this in the upper half of the range.</li>
            <li><strong>Free T3:</strong> The active hormone. This is the "gasoline" for the mitochondria. Low Free T3 is the primary driver of "Meno-fog."</li>
            <li><strong>Reverse T3 (rT3):</strong> The "brake pedal." High rT3 (often caused by high cortisol, discussed in the 'H' Pillar) blocks T3 from entering the cells.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 1: The Metabolic Stall</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.8)">Estrogen Dominance vs. Subclinical Hypothyroidism</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 44</h4>
                        <p>Presenting: 14lb weight gain in 6 months, thinning outer eyebrows, and 3:00 AM wakefulness.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Sarah assumed she was in perimenopause because her periods were becoming shorter (24 days). She had increased her exercise and decreased calories, but her weight continued to climb‚Äîa classic <span class="highlight">Metabolic Stall</span>.</p>
                <p><strong>The Data:</strong>
                <ul>
                    <li>TSH: 3.8 mIU/L (Technically "normal" per her GP)</li>
                    <li>Free T3: 2.4 pg/mL (Low-optimal)</li>
                    <li>FSH: 14 IU/L (Early perimenopause range)</li>
                    <li>Progesterone: Low luteal phase (indicating anovulatory cycles)</li>
                </ul>
                </p>
                <p><strong>The Intervention:</strong> Sarah didn't just have perimenopause; she had <span class="highlight">Estrogen Dominance induced Hypothyroidism</span>. High estrogen levels increase Thyroid Binding Globulin (TBG), which "soaks up" free thyroid hormone, making it unavailable to her cells.</p>
                <p><strong>Outcome:</strong> By implementing the <strong>Hormone Harmony (H)</strong> protocol (supporting progesterone) and the <strong>Reset Metabolism (R)</strong> protocol (increasing selenium and zinc for T4-to-T3 conversion), Sarah lost 9lbs in 8 weeks and regained her morning energy.</p>
            </div>
        </div>

        <h2 id="section4">4. The Estrogen-Thyroid Connection</h2>
        <p>One of the most critical mechanisms you must understand as a Level 2 practitioner is how the HPG and HPT axes interact biochemically. This is the "Why" behind the "What."</p>
        
        <p>When a woman enters perimenopause, her progesterone often drops first, leading to relative <span class="highlight">Estrogen Dominance</span>. Estrogen has a direct stimulatory effect on the liver to produce <strong>Thyroid Binding Globulin (TBG)</strong>. Think of TBG as a taxi cab for thyroid hormones. If there are too many taxi cabs, the thyroid hormones stay "locked" inside the cab and cannot exit to enter the cells (the destination). </p>

        <p>This explains why a woman can have a "perfect" TSH and T4, but feel like her metabolism has completely shut down. She has plenty of hormone, but it is <span class="highlight">biologically inactive</span> because it is bound to TBG.</p>

        <h2 id="section5">5. Utilizing the T.H.R.I.V.E. Methodology‚Ñ¢ for Differential Support</h2>
        <p>Once you have identified that a client is dealing with an overlap, your coaching plan must address both systems. You cannot "Reset Metabolism" if the thyroid is under-fueled, and you cannot "Harmonize Hormones" if the thyroid is slowing down the clearance of estrogen.</p>

        <h3>The Dual-Track Support Plan:</h3>
        <div class="principle-card">
            <div class="principle-title">Pillar H: Hormone Harmony (The Foundation)</div>
            <p class="principle-text">Focus on clearing the "Estrogen Logjam" to lower TBG levels.
                <ul>
                    <li>Support Phase I and II liver detoxification (Cruciferous vegetables, Calcium D-Glucarate).</li>
                    <li>Promote progesterone production to balance the estrogen-to-thyroid ratio.</li>
                </ul>
            </p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Pillar R: Reset Metabolism (The Catalyst)</div>
            <p class="principle-text">Focus on the nutrients required for thyroid hormone conversion.
                <ul>
                    <li><strong>Selenium:</strong> Essential for the deiodinase enzymes that convert T4 to T3.</li>
                    <li><strong>Iodine/Tyrosine:</strong> The raw building blocks of thyroid hormone.</li>
                    <li><strong>Caloric Adequacy:</strong> Warning! Chronic undereating (common in perimenopausal women trying to lose weight) triggers the body to increase Reverse T3, further slowing the metabolism.</li>
                </ul>
            </p>
        </div>

        <h2 id="section6">6. Red Flags: When to Refer Out</h2>
        <p>As per our Scope of Practice (Module 0, L3), coaches do not diagnose or treat disease. You are an <strong>Endocrine Detective</strong>. If your tracking reveals any of the following, an immediate referral to a functional endocrinologist or literate GP is mandatory:</p>
        <ul>
            <li><strong>Palpable nodules</strong> or swelling in the neck (goiter).</li>
            <li><strong>Rapid heart rate</strong> (resting HR >100 bpm) or tremors (signs of hyperthyroidism/Graves).</li>
            <li><strong>TSH > 10</strong> (Clinical hypothyroidism requiring medication).</li>
            <li><strong>Sudden, unexplained hair loss</strong> in large clumps (potential Hashimoto‚Äôs/Autoimmunity).</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning on thyroid-menopause overlap.</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">A client presents with "brain fog" and weight gain. Her TSH is 3.5 and her Estradiol is high. Why might she still feel hypothyroid despite a "normal" TSH?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    High estrogen levels stimulate the production of Thyroid Binding Globulin (TBG). This binds to free thyroid hormones, making them unavailable to the tissues. Despite a normal TSH, she likely has low "Free" hormone levels (tissue-level hypothyroidism).
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Which T.H.R.I.V.E. pillar is most effective for distinguishing between cyclical perimenopausal fatigue and constant thyroid fatigue?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The <strong>Track Symptoms (T)</strong> pillar. By mapping symptoms over 1-2 cycles, we can see if the fatigue follows the hormonal fluctuations of the menstrual cycle (Perimenopause) or remains constant and linear (Thyroid).
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Lesson Takeaways</p>
            <ul>
                <li><strong>The Hypothalamic Link:</strong> Thyroid and sex hormones are inextricably linked via the hypothalamus; dysfunction in one often impacts the other.</li>
                <li><strong>Optimal is not "Normal":</strong> A TSH above 2.0 or 2.5 is often a sign of subclinical dysfunction in the context of perimenopause.</li>
                <li><strong>The Estrogen Trap:</strong> Estrogen dominance can effectively "kidnap" thyroid hormones by increasing binding proteins (TBG).</li>
                <li><strong>Conversion is Key:</strong> Many women have enough T4 (storage) but cannot convert it to T3 (active) due to stress (high cortisol) or nutrient deficiencies.</li>
                <li><strong>Track the Velocity:</strong> Use the 'T' pillar to determine if symptoms are cyclical or constant.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Santoro, N. et al. (2021). "The Menopause Transition: Signs, Symptoms, and Thyroid Overlap." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
                <li>Biondi, B. et al. (2019). "The Clinical Significance of Subclinical Thyroid Dysfunction." <em>Endocrine Reviews.</em></li>
                <li>Mazer, N.A. (2004). "Interaction of Estrogen Therapy and Thyroid Hormone." <em>Thyroid Journal.</em></li>
                <li>Pearce, E.N. (2007). "Thyroid Dysfunction in Perimenopausal and Postmenopausal Women." <em>Menopause International.</em></li>
                <li>AccrediPro Research Group (2023). "The T.H.R.I.V.E. Methodology‚Ñ¢: Integrating Endocrine Tracking in Midlife Coaching." <em>Internal Practitioner Review.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy‚Ñ¢ | Menopause Support Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>